Effect of Thiol-reducing Agents and Antioxidants on Sulfasalazine-induced Hepatic Injury in Normotermic Recirculating Isolated Perfused Rat Liver |
Heidari, Reza
(Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences)
Esmailie, Neda (Department of Pharmacology and Toxicology, Faculty of Pharmacy, Shiraz University of Medical Sciences) Azarpira, Negar (Transplant Research Center, Shiraz University of Medical Sciences) Najibi, Asma (Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences) Niknahad, Hossein (Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences) |
1 | Makarova, S.I. (2008) Human N-acetyltransferases and druginduced hepatotoxicity. Curr. Drug Metab., 9, 538-545. DOI |
2 | Wahl, C., Liptay, S., Adler, G. and Schmid, R.M. (1998) Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B. J. Clin. Invest., 101, 1163-1174. DOI |
3 | Liptay, S., Bachem, M., Hacker, G., Adler, G., Debatin, K.M. and Schmid, R.M. (1999) Inhibition of nuclear factor kappa B and induction of apoptosis in T-lymphocytes by sulfasalazine. Br. J. Pharmacol., 128, 1361-1369. DOI |
4 | Yamamoto, Y. and Gaynor, R.B. (2001) Therapeutic potential of inhibition of the NF-B pathway in the treatment of inflammation and cancer. J. Clin. Invest., 107, 135-142. DOI |
5 | Karin, M. and Lin, A. (2002) NF-B at the crossroads of life and death. Nat. Immunol., 3, 221-227. |
6 | Mihas, A.A., Goldenberg, D.J. and Slaughter, R.L. (1978) Sulfasalazine toxic reactions: hepatitis, fever, and skin rash with hypocomplementemia and immune complexes. JAMA, 239, 2590-2591. DOI |
7 | Boyer, D.L., Li, B.U., Fyda, J.N. and Friedman, R.A. (1989) Sulfasalazine-induced hepatotoxicity in children with inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr., 8, 528-532. DOI |
8 | Holt, M.P. and Ju, C. (2006) Mechanisms of drug-induced liver injury. AAPS J., 8, E48-E54. DOI |
9 | Abdoli, N., Heidari, R., Azarmi, Y. and Eghbal, M.A. (2013) Mechanisms of the statins cytotoxicity in freshly isolated rat hepatocytes. J. Biochem. Mol. Toxicol., 27, 287-294. DOI |
10 | Heidari, R., Niknahad, H., Jamshidzadeh, A. and Abdoli, N. (2014) Factors affecting drug-induced liver injury: antithyroid drugs as instances. Clin. Mol. Hepatol., 20, 237-248. DOI |
11 | Heidari, R., Niknahad, H., Jamshidzadeh, A., Eghbal, M.A. and Abdoli, N. (2015) An overview on the proposed mechanisms of antithyroid drugs-induced liver injury. Adv. Pharm. Bull., 5, 1-11. |
12 | Rains, C.P., Noble, S. and Faulds, D. (1995) Sulfasalazine. A review of its pharmacological properties and therapeutic efficacy in the treatment of rheumatoid arthritis. Drugs, 50, 137-156. DOI |
13 | de Abajo, F.J., Montero, D., Madurga, M. and Garcia Rodriguez, L.A. (2004) Acute and clinically relevant drug-induced liver injury: a population based case-control study. Br. J. Clin. Pharmacol., 58, 71-80. DOI |
14 | Khokhar, O.S. and Lewis, J.H. (2010) Hepatotoxicity of agents used in the management of inflammatory bowel disease. Dig. Dis., 28, 508-518. DOI |
15 | Marinos, G., Riley, J., Painter, D.M. and McCaughan, G.W. (1992) Sulfasalazine-induced fulminant hepatic failure. J. Clin. Gastroenterol., 14, 132-135. DOI |
16 | Linares, V., Alonso, V., Albina, M.L., Belles, M., Sirvent, J.J., Domingo, J.L. and Sanchez, D.J. (2009) Lipid peroxidation and antioxidant status in kidney and liver of rats treated with sulfasalazine. Toxicology, 256, 152-156. DOI |
17 | Rubin, R. (1994) Sulfasalazine-induced fulminant hepatic failure and necrotizing pancreatitis. Am. J. Gastroenterol., 89, 789-91. |
18 | Ransford, R.A. and Langman, M.J. (2002) Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the committee on safety of medicines. Gut, 51, 536-539. DOI |
19 | Jobanputra, P., Amarasena, R., Maggs, F., Homer, D., Bowman, S., Rankin, E., Filer, A., Raza, K. and Jubb, R. (2008) Hepatotoxicity associated with sulfasalazine in inflammatory arthritis: a case series from a local surveillance of serious adverse events. BMC Musculoskelet. Disord., 9, 48. DOI |
20 | Linares, V., Alonso, V. and Domingo, J.L. (2011) Oxidative stress as a mechanism underlying sulfasalazine-induced toxicity. Expert Opin. Drug Saf., 10, 253-263. DOI |
21 | Alonso, V., Linares, V., Belles, M., Albina, M.L., Sirvent, J.J., Domingo, J.L. and Sanchez, D.J. (2009) Sulfasalazine induced oxidative stress: A possible mechanism of male infertility. Reprod. Toxicol., 27, 35-40. DOI |
22 | Wolkoff, A.W., Johansen, K.L. and Goeser, T. (1987) The isolated perfused rat liver: preparation and application. Anal. Biochem., 167, 1-14. DOI |
23 | Ferrigno, A., Richelmi, P. and Vairetti, M. (2013) Troubleshooting and improving the mouse and rat isolated perfused liver preparation. J. Pharmacol. Toxicol. Methods, 67, 107-114. DOI |
24 | Sedlak, J. and Lindsay, R.H. (1968) estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal. Biochem., 25, 192-205. DOI |
25 | Bessems, M., 't Hart, N.A., Tolba, R., Doorschodt, B.M., Leuvenink, H.G., Ploeg, R.J., Minor, T. and van Gulik, T.M. (2006) The isolated perfused rat liver: standardization of a time-honoured model. Lab. Anim., 40, 236-246. DOI |
26 | Heidari, R., Jamshidzadeh, A., Keshavarz, N. and Azarpira, N. (2015) Mitigation of methimazole-induced hepatic injury by taurine in mice. Sci. Pharm., 83, 143-158. DOI |
27 | Heidari, R., Babaei, H. and Eghbal, M.A. (2013) cytoprotective effects of organosulfur compounds against methimazoleinduced toxicity in isolated rat hepatocytes. Adv. Pharm. Bull., 3, 135-142. |
28 | Heidari, R., Babaei, H., Roshangar, L. and Eghbal, M.A. (2014) Effects of enzyme induction and/or glutathione depletion on methimazole-induced hepatotoxicity in mice and the protective role of N-acetylcysteine. Adv. Pharm. Bull., 4, 21-28. |
29 | Gabay, C., De Bandt, M. and Palazzo, E. (1993) Sulphasalazine-related life-threatening side effects: is N-acetylcysteine of therapeutic value? Clin. Exp. Rheumatol., 11, 417-20. |
30 | Sleire, L., Skeie, B.S., Netland, I.A., Forde, H.E., Dodoo, E., Selheim, F., Leiss, L., Heggdal, J.I., Pedersen, P.H., Wang, J. and Enger, P.O. (2015) Drug repurposing: sulfasalazine sensitizes gliomas to gamma knife radiosurgery by blocking cystine uptake through system , leading to glutathione depletion. Oncogene, 34, 5951-5959. DOI |
31 | Plosker, G.L. and Croom, K.F. (2005) Sulfasalazine: a review of its use in the management of rheumatoid arthritis. Drugs, 65, 1825-1849. DOI |